These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 34420762)
1. Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review. Cui M; Zhang M; Liu K Carbohydr Polym; 2021 Nov; 272():118530. PubMed ID: 34420762 [TBL] [Abstract][Full Text] [Related]
2. Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery. Zhang L; Sang Y; Feng J; Li Z; Zhao A J Drug Target; 2016 Aug; 24(7):579-89. PubMed ID: 26766303 [TBL] [Abstract][Full Text] [Related]
3. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Hua S; Marks E; Schneider JJ; Keely S Nanomedicine; 2015 Jul; 11(5):1117-32. PubMed ID: 25784453 [TBL] [Abstract][Full Text] [Related]
4. Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy. Long J; Liang X; Ao Z; Tang X; Li C; Yan K; Yu X; Wan Y; Li Y; Li C; Zhou M Acta Biomater; 2024 Oct; 188():27-47. PubMed ID: 39265673 [TBL] [Abstract][Full Text] [Related]
5. Comparative Efficacy of Chitosan, Pectin Based Mesalamine Colon Targeted Drug Delivery Systems on TNBS-induced IBD Model Rats. Newton AMJ; Lakshmanan P Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):113-127. PubMed ID: 30657050 [TBL] [Abstract][Full Text] [Related]
6. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols. Tie S; Tan M J Agric Food Chem; 2022 Feb; 70(4):903-915. PubMed ID: 35072455 [TBL] [Abstract][Full Text] [Related]
7. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746 [TBL] [Abstract][Full Text] [Related]
8. Dual-Sensitive Carbohydrate-Based Nanosystem for Targeted Drug Delivery to Potentiate the Therapeutic Efficacy of Ulcerative Colitis. Wang Y; Song X; Cui R; Luo X; Dong J; Wang H; Song C; Zhou Y; Cui S Int J Nanomedicine; 2024; 19():8555-8572. PubMed ID: 39185345 [TBL] [Abstract][Full Text] [Related]
9. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Guo Y; Zong S; Pu Y; Xu B; Zhang T; Wang B Molecules; 2018 Jul; 23(7):. PubMed ID: 29973488 [TBL] [Abstract][Full Text] [Related]
10. Potential interventions and interactions of bioactive polyphenols and functional polysaccharides to alleviate inflammatory bowel disease - A review. Farid MS; Shafique B; Xu R; Łopusiewicz Ł; Zhao C Food Chem; 2025 Jan; 462():140951. PubMed ID: 39213975 [TBL] [Abstract][Full Text] [Related]
11. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides. Yuan H; Guo C; Liu L; Zhao L; Zhang Y; Yin T; He H; Gou J; Pan B; Tang X Carbohydr Polym; 2023 Jul; 312():120838. PubMed ID: 37059563 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. Yang C; Merlin D Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785 [TBL] [Abstract][Full Text] [Related]
13. The Role of Nanoparticle Morphology on Enhancing Delivery of Budesonide for Treatment of Inflammatory Bowel Disease. Li Q; Liu W; Liu K; Dong Z; Kong W; Lu X; Wei Y; Wu W; Yang J; Qi J ACS Appl Mater Interfaces; 2024 Jul; 16(26):33081-33092. PubMed ID: 38888094 [TBL] [Abstract][Full Text] [Related]
14. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease. Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374 [TBL] [Abstract][Full Text] [Related]
15. Research progress in the treatment of inflammatory bowel disease with natural polysaccharides and related structure-activity relationships. Chen J; Gao Y; Zhang Y; Wang M Food Funct; 2024 Jun; 15(11):5680-5702. PubMed ID: 38738935 [TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Hadji H; Bouchemal K Adv Drug Deliv Rev; 2022 Feb; 181():114101. PubMed ID: 34999122 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease. Beloqui A; Memvanga PB; Coco R; Reimondez-Troitiño S; Alhouayek M; Muccioli GG; Alonso MJ; Csaba N; de la Fuente M; Préat V Colloids Surf B Biointerfaces; 2016 Jul; 143():327-335. PubMed ID: 27022873 [TBL] [Abstract][Full Text] [Related]
18. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Zeeshan M; Ali H; Khan S; Khan SA; Weigmann B Int J Pharm; 2019 Mar; 558():201-214. PubMed ID: 30615925 [TBL] [Abstract][Full Text] [Related]
19. Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs. Beloqui A; Coco R; Préat V Curr Pharm Des; 2016; 22(40):6192-6206. PubMed ID: 26864312 [TBL] [Abstract][Full Text] [Related]